Ardent Health (NYSE:ARDT – Get Free Report) issued its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.06), FiscalAI reports. The company had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%. Ardent Health updated its FY 2026 guidance to 0.780-1.150 EPS.
Ardent Health Stock Performance
Shares of NYSE:ARDT traded down $0.17 on Thursday, hitting $10.98. The company’s stock had a trading volume of 10,435 shares, compared to its average volume of 449,700. Ardent Health has a 12 month low of $7.71 and a 12 month high of $15.48. The company has a market capitalization of $1.55 billion, a price-to-earnings ratio of 19.96, a price-to-earnings-growth ratio of 3.04 and a beta of 0.71. The stock’s 50-day moving average is $10.76 and its two-hundred day moving average is $9.84. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.99 and a current ratio of 2.10.
Analysts Set New Price Targets
Several research firms have recently commented on ARDT. Weiss Ratings lowered shares of Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. Zacks Research upgraded shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Monday. Guggenheim boosted their target price on shares of Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Royal Bank Of Canada upped their target price on shares of Ardent Health from $12.00 to $13.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Finally, The Goldman Sachs Group restated a “neutral” rating and issued a $13.00 price target on shares of Ardent Health in a research note on Thursday, August 6th. Seven analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $13.05.
Institutional Investors Weigh In On Ardent Health
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Goldentree Asset Management LP grew its position in Ardent Health by 99.7% in the 4th quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock valued at $20,302,000 after buying an additional 1,150,000 shares in the last quarter. Ameriprise Financial Inc. raised its position in shares of Ardent Health by 8.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,769,335 shares of the company’s stock worth $23,444,000 after buying an additional 134,513 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of Ardent Health by 44.5% in the 3rd quarter. Vanguard Group Inc. now owns 1,352,676 shares of the company’s stock worth $17,923,000 after acquiring an additional 416,348 shares during the period. Millennium Management LLC lifted its stake in shares of Ardent Health by 6.6% in the 3rd quarter. Millennium Management LLC now owns 1,269,605 shares of the company’s stock worth $16,822,000 after acquiring an additional 78,861 shares during the period. Finally, Bridgeway Capital Management LLC boosted its holdings in shares of Ardent Health by 108.2% in the fourth quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock valued at $8,358,000 after acquiring an additional 491,961 shares in the last quarter.
Ardent Health Company Profile
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Further Reading
- Five stocks we like better than Ardent Health
- This Corner of the Market Is Outperforming the Benchmark—And It’s Not AI
- Victoria’s Secret’s Comeback Is Real—The Stock’s Problem Is Different
- Apple Unveils Foldable iPhone, But Stock’s Muted Reaction Raises Questions
- Palantir’s New U.S. Army Contract Brings It Closer to Owning the Full Battlefield System
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
